Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01436851
Other study ID # 2009/265
Secondary ID
Status Completed
Phase N/A
First received August 16, 2011
Last updated August 14, 2017
Start date November 24, 2010
Est. completion date December 2014

Study information

Verified date August 2017
Source Haukeland University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In a previous study the investigators found that many bakery workers were sensitized to storage mites, and many had rhinitis symptoms. The role of storage mites as an occupational allergen with clinical relevance has been questioned, and the investigators wanted to investigate whether a nasal provocation with a storage mite extract would trigger symptoms and objective signs of rhinitis in bakery workers and a control group.


Description:

The investigations include allergy testing with skin prick testing, and measuring of specific Immunoglobulin E (IgE) in sera, answering a questionnaire, and symptom scoring before and after provocations. The participants will be investigated one day with a placebo, and another day with the allergen extract of either Acarus Siro or Lepidoglyphus Destructor. As a measurement of nasal patency we use the nasal peak inspiratory flow meter, but also clinical scoring of nasal secretion and blockage. Indices of inflammation (ECP and alfa-Macroglobulin) will be monitored in nasal lavage.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date December 2014
Est. primary completion date September 1, 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- bakery workers

- > 18 years

- sensitized to a storage mite (A.Siro or L. Destructor)

Exclusion Criteria:

- pregnant or breast-feeding

- infection in upper or lower airways the last month

- nasal polyposis

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Storage mite allergen extracts
Nasal provocation with increasing doses of storage mite allergen extracts

Locations

Country Name City State
Norway Dept. of Occupational Medicine, Haukeland University Hospital Bergen

Sponsors (1)

Lead Sponsor Collaborator
Haukeland University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurements of indices of inflammation in nasal lavage after specific nasal provocation with storage mite allergen Indices of inflammation (alfa2-macroglobulin, eosinophil cationic protein) in nasal lavage after specific nasal provocation with storage mite allergen (Acarus Siro or Lepidoglyphus Destructor) twice, the second provocation with doubled allergen concentration Change from baseline to 10 minutes after nasal provocation
Secondary Rhinitis symptoms after specific nasal provocation with storage mite allergen glyphus Destructor) Rhinitis symptoms measured by symptoms score and visual analog scale, before and after specific nasal provocation with storage mite allergen (Acarus Siro, Lepidoglyphus Destructor) twice, the second time with doubled concentration of allergen Change from baseline to 10 minutes after provocation
Secondary Reduction in nasal patency measured by peak nasal inspiratory flow meter after specific nasal provocation with storage mite allergen Reduction in nasal patency measured by peak nasal inspiratory flow meter before and after specific nasal provocation with storage mite allergen (Acarus Siro, Lepidoglyphus Destructor) twice, the second time with doubled concentration of allergen Change from baseline to 10 minutes after provocation
Secondary Objective signs of rhinitis assessed by rhinoscopy after specific nasal provocation with storage mite allergen Objective signs of rhinitis assessed by anterior rhinoscopy, and notified as a clinical score before and after specific nasal provocation with storage mite allergen (Acarus Siro, Lepidoglyphus Destructor) twice, second time with the doubled allergen concentration Change from baseline to 10 minutes after provocation
See also
  Status Clinical Trial Phase
Completed NCT01231464 - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis Phase 3
Completed NCT01068808 - The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis N/A
Completed NCT01326247 - Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis Phase 4